Page last updated: 2024-09-03

imatinib mesylate and Pulmonary Aspergillosis

imatinib mesylate has been researched along with Pulmonary Aspergillosis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
De Langhe, E; Hillen, A; Himmelreich, U; Lories, RJ; Poelmans, J; Vande Velde, G; Vanoirbeek, J1

Other Studies

1 other study(ies) available for imatinib mesylate and Pulmonary Aspergillosis

ArticleYear
Longitudinal micro-CT provides biomarkers of lung disease that can be used to assess the effect of therapy in preclinical mouse models, and reveal compensatory changes in lung volume.
    Disease models & mechanisms, 2016, Volume: 9, Issue:1

    Topics: Animals; Biomarkers; Bleomycin; Cryptococcosis; Disease Models, Animal; Fibrosis; Imatinib Mesylate; Inflammation; Lung; Lung Diseases; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Pulmonary Aspergillosis; X-Ray Microtomography

2016